The recall notice, which the FDA says is a "correction" rather than a product removal. HealthDay News — The US Food and Drug Administration has issued a Class 1 recall — its most urgent kind — for an ...

Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5%. HealthDay News — Diagnostic targeted Botox injections have high positive predictive value for migraine ...

Patients with early Parkinson disease who received lixisenatide had a decrease in motor disability progression, but they also experienced gastrointestinal side effects. Lixisenatide vs placebo is ...

The ACC recently issued an expert consensus decision pathway for treatment of HFrEF for 2024. The American College of Cardiology (ACC) released an expert consensus decision pathway in the Journal of ...

At 1 and 5 years after surgery, risk for venous thromboembolism and pulmonary embolism was lower. HealthDay News — In the short term, bariatric surgery is associated with a greater risk for venous ...

Tool included 19 variables and had good predictive accuracy, identifying those who did not qualify for palivizumab. HealthDay News — A personalized tool can predict infants at increased risk for ...

The first case involved a patient who sued a hospital after he found out that someone he hadn’t told about his diagnosis was aware of it. In January, the patient, Mr W, who was the owner of an ...

A regulatory decision is expected in the fourth quarter of 2024. The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for tapinarof cream, 1% for the ...

Extreme heat is one of the most dangerous meteorological phenomena, causing nearly 400 premature deaths a year in New York City.

Compared with children with epilepsy who received assessment-enhanced usual care, those who received MICE therapy demonstrated improved symptoms of emotional and behavioral difficulties. Young ...

More than 1 in 5 older men with low life expectancy still undergo PSA screening for prostate cancer. More than 1 in 5 older men with low life expectancy still undergo PSA screening for prostate cancer ...